Medical/Pharmaceuticals

Mayne Pharma Executes 20 Year License and Supply Agreement for Novel Oral Contraceptive in Australia

ADELAIDE, Australia, May 28, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce it has entered into an exclusive long-term license and supply agreement with Mithra Pharmaceuticals SA (Mithra) to commercialise E4/DRSP, a combined oral contraceptive, inAustralia. E4...

2020-05-28 17:23 6412

Merck and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living With MS

- Merck and Twitch collaborate on World MS Day to increase understanding of the impact of multiple sclerosis (MS) - Livestream event with Twitch influencers on May 30 will raise awareness and money for the MS International Federation and help connect people affected by the disease, in line ...

2020-05-28 16:00 2947

Seaweed Extract Offers Hope for Influenza A

CAMBRIDGE, Australia, May 28, 2020 /PRNewswire/ --  Australian scientists have revealed that a natural compound found in seaweed may reduce the effects of severe cases of Influenza A. Fucoidan is a highly bioactive compound found naturally in brown seaweed and well known for its diverse therapeu...

2020-05-28 15:30 1175

CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2

LUXEMBOURG, May 28, 2020 /PRNewswire/ -- CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agreement withModerna, Inc. (Nasda...

2020-05-28 13:30 5802

Mayapada Healthcare Ready to Serve PCR Swab Covid-19

JAKARTA, Indonesia, May 28, 2020 /PRNewswire/ -- Mayapada Healthcare is ready to serve the PCR Swab Test in all Mayapada Hospital units. Supported by specialized Biomolecular Laboratory, certified Bio Safety Level 2 (BSL2), PCR equipment with the latest technology, and experts in their fields, Ma...

2020-05-28 11:00 2996

Shanghai Cell Therapy Group Launches Collaboration with USC researcher to Improve the ex vivo Expansion of Hematopoietic Stem Cells for Clinical Applications

SHANGHAI, May 27, 2020 /PRNewswire/ -- Shanghai Cell Therapy Group (SHCell) recently entered into a six-year research collaborative project with Professor Qi-Long Ying from theUniversity of Southern California (USC). Through the project, sponsored by$3.6 million from the Baize Plan Fund, the Ying...

2020-05-28 10:35 1219

Yuyu Pharma Signs Contract for Baseball Field Ad Campaign

SEOUL, South Korea, May 28, 2020 /PRNewswire/ -- Yuyu Pharma  (CEO Robert Wonsang Yu, KRX 000220), a Korean pharmaceutical company, recently signed an advertising contract with the Korea Economic Daily, which holds the advertising business rights of the Jamsil Baseball ...

2020-05-28 08:00 5671

I-Mab Reports Interim Results from Part 1 Study for Anti-GM-CSF Antibody TJM2 to Treat COVID-19 Patients with Cytokine Release Syndrome

SHANGHAI and GAITHERSBURG, MD, May 27, 2020 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced interim results from a multi-center, double blinded, randomized, placeb...

2020-05-28 04:05 1869

Transcenta Presents First Data from Phase 1 Study of pH-Dependent PDL1 Antibody MSB2311 in Patients with Pre-treated Advanced Solid Tumors and Select Hematological Malignancies

SUZHOU, China, May 27, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery,development and manufacturing of antibody-based therapeutics, announced today results reported for the first time from a Phase 1...

2020-05-27 23:00 1226

Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

-- Company will focus on process development and improvements for manufacturing Baylor's Covid-19 vaccine candidates DARMSTADT, Germany, May 27, 2020 /PRNewswire/ -- Merck, a leading science and technology company, andBaylor College of Medicine, Houston, Texas, USA, today announced an extensio...

2020-05-27 21:15 3712

ActLight Signs an Agreement on Single Photon Sensitivity Technology With Leading Sensors Company

LAUSANNE, Switzerland, May 27, 2020 /PRNewswire/ -- ActLight, the Swiss technology firm known for its best in class signal-to-noise ratio photodiodes, announced today that it has signed a service agreement based on its Single Photon Sensitivity technology with a leading company in the sensors mar...

2020-05-27 20:52 2209

Ajinomoto Bio-Pharma Services Signs Manufacturing Agreement with Humanigen for Lenzilumab, Currently in FDA-Approved Phase III Study for COVID-19

SAN DIEGO, May 27, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing agreement with Humanigen, Inc., for the fill finish supply ...

2020-05-27 20:07 2326

Daewoong Pharmaceutical Acquires Halal Certification for 'Easyef' through Daewoong Infion

SEOUL, South Korea and JAKARTA, Indonesia, May 27, 2020 /PRNewswire/ -- Daewoong Pharmaceutical (CEOSengho Jeon) announced on May 25 that the Indonesian joint venture Daewoong Infion (CEOChang Woo Suh) obtained Halal certification for the diabetic foot ulcer drug 'Easyef topical solution(Easyef)...

2020-05-27 10:00 4389

DERMALOG Fever Check at German Baltic Hotel

USEDOM and HAMBURG, Germany, May 27, 2020 /PRNewswire/ --  - Picture is available at AP Images (http://www.apimages.com ) - In the course of the Corona pandemic, the hospitality industry has come under increased scrutiny by public authorities. Incidents such as the Covi...

2020-05-27 00:41 2622

Orteq® Sports Medicine Announces Publication of 5-year Multi-Center Clinical Data for the Actifit® Meniscal Scaffold in the American Journal of Sports Medicine (AJSM), Receives FDA Breakthrough Device Designation

LONDON, May 26, 2020 /PRNewswire/ -- Orteq Sports Medicine Ltd. (www.orteq.com ), a developer of joint preservation solutions for orthopedic patients, announces 5-year, multi center, peer-reviewed data published in the AJSM analyzing the Actifit meniscal scaffold that shows more than 87% survival ...

2020-05-26 20:00 3423

United Imaging uMR OMEGA Cleared by FDA, Available in U.S. Market

HOUSTON, May 26, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced U.S. Food & Drug Administration (FDA) clearance of the uMR OMEGATM magnetic resonance imaging (MRI) scanner. The uMR OMEGA offers the world's first ultra-wide 75...

2020-05-26 20:00 1532

EDAN CEO: Mushroomed under the Crisis

SHENZHEN, China, May 26, 2020 /PRNewswire/ -- A critical medical device provider of the COVID-19 pandemic, EDAN, supplied hundreds of thousands of medical devices toGermany, Spain, Italy, the United Kingdom, the United States, Russia, Mexico, Brazil, and many other countries. Hao Zhang, the CEO o...

2020-05-26 16:33 2897

Polygiene Treating Respirators From Carbonado With ViralOff

- Indian brand Carbonado just launched AerFit NEO respirators with Polygiene ViralOff® textile treatment technology STOCKHOLM, May 26, 2020 /PRNewswire/ -- The company will place orders in volumes of 500,000 to one million (1,000,000) respirators in the coming three to six months and has a broad...

2020-05-26 14:46 2376

AFT Pharmaceuticals Donates Almost $110,000 To Health Charities When They Need It Most

SYDNEY, May 26, 2020 /PRNewswire/ -- Three health charities have been given a much-needed boost at a time when the charity sector, which relies heavily on income from public events and other in-person fundraising initiatives, is being impacted by the COVID-19 pandemic. Starlight Children's Founda...

2020-05-26 08:46 2551

Nucleus Network commences Novavax' Phase 1/2 COVID-19 vaccine trial in Australia

MELBOURNE, Australia, May 26, 2020 /PRNewswire/ -- Australia's largest Phase 1 Clinical trials specialist, Nucleus Network, has today commenced dosing the first human participants for the Phase 1/2 trial of NVX‑CoV2373, a SARS-CoV-2 Recombinant Spike Protein Nanoparticle vaccine, at itsMelbourne ...

2020-05-26 08:41 2310
1 ... 561562563564565566567 ... 608